KHOREN HEKIMIAN: Open Payments
NPI 1588695423 · TROUP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,339 in 54 payments from 10 companies in 2025. Trend: 2023 $1,140 · 2024 $1,038 · 2025 $6,339
Consulting: $3,738Food & beverage: $2,098Travel & lodging: $493Education: $9
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 15 | $4,771 |
| Alpha Cognition USA, Inc. | 4 | $528 |
| Neurocrine BioSciences, Inc. | 10 | $503 |
| Teva Pharmaceuticals USA, Inc. | 10 | $179 |
| ACADIA Pharmaceuticals Inc | 6 | $139 |
| UCB, Inc. | 2 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $48 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: YUPELRI, Zunveyl, INGREZZA, AUSTEDO XR, NUPLAZID, REXULTI, Briviact, Auvelity.
Industry payments across TX — which companies pay providers there.
